Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany.

about

[Outpatient care and disease burden of rheumatoid arthritis : Results of a linkage of claims data and a survey of insured persons].Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.

P2860

Q36316669-FA6A548D-EB5E-40A4-A7AE-70E6DD705F97 Q47207085-9D6F1527-A275-4A52-B399-E71D89600986

P2860

Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany.

Item

http://www.wikidata.org/entity/Q37303008

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany.

@en

Frequency and trends of disease-modifying antirheumatic drug

@nl

type

Item

label

Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany.

@en

Frequency and trends of disease-modifying antirheumatic drug

@nl

prefLabel

Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany.

@en

Frequency and trends of disease-modifying antirheumatic drug

@nl

P1476

Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany.

@en

P2093

Alexander M Fassmer

http://www.w3.org/2001/XMLSchema#string

Edeltraut Garbe

http://www.w3.org/2001/XMLSchema#string

Niklas Schmedt

http://www.w3.org/2001/XMLSchema#string

P2860

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study

Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population.

A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers

Contribution of obesity to the rise in incidence of rheumatoid arthritis

Changes in use of disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States during 1983-2009.

Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia.

Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting.

TNF inhibitors - Mechanisms of action, approved and off-label indications.

P304

e00254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRP2.254

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27713825

http://www.w3.org/2001/XMLSchema#string

P921

A' Ghearmailt

P932

5045940

http://www.w3.org/2001/XMLSchema#string

Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany.

about

P2860

P2860

Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932